precision medicine

Precision Medicine in Type 1 Diabetes Prevention: Long-Term Delayed Onset of Stage 3 Diabetes After GAD-Alum Treatment in HLA-DR3-DQ2-Positive Children

By MedXY 10/04/2026

GAD-alum immunotherapy significantly delays progression to stage 3 type 1 diabetes in children positive for the HLA-DR3-DQ2 haplotype, underscoring precision medicine's role in managing autoimmunity.

Cardiology news

Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

By MedXY 09/28/2026

A phase 2 clinical study demonstrates that lumacaftor safely shortens QTc in LQT2 patients with KCNH2 trafficking defects, supported by patient-specific cardiomyocyte models validating the mechanism.

Hematology-Oncology news Oncology

Precision Immunotherapy in Acute Myeloid Leukemia: Advancing Beyond Traditional Targets

By MedXY 09/28/2026

Recent advances in identifying leukemia-restricted antigens enable subtype-specific immunotherapies in AML that selectively target malignant cells while sparing normal hematopoiesis, offering a promising new paradigm for precision treatment.

Hematology-Oncology news Oncology

Decoding Large B Cell Lymphoma Heterogeneity: A Single-Cell Atlas Identifies Malignant Archetypes Linked to Patient Outcomes

By MedXY 09/26/2026

A comprehensive single-cell RNA sequencing study of large B cell lymphomas reveals five malignant B cell archetypes, with one subtype predictive of poor treatment response and survival, paving the way for precision therapy in LBCL.

Cardiology Hematology-Oncology news

Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis: A Precision Medicine Imperative

By MedXY 09/14/2026

Clonal hematopoiesis of indeterminate potential (CHIP) poses a novel cardiovascular risk. This article explores challenges and strategies for designing cardiovascular outcomes trials tailored to CHIP’s genetic heterogeneity and clinical complexity.

Cardiology Clinical Updates news Pediatrics Respiratory

Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions

By MedXY 09/13/2026

Rapid immunoassay-based classifiers accurately identify hyper- and hypoinflammatory subphenotypes in critically ill children, preserving prognostic and predictive utility and enabling precision therapies in acute pediatric cardiorespiratory failure.

Diabetes & Endocrinology news

Coordinated Precision Care for Rare Genetic Obesity: European Expert Consensus on Centers of Expertise and Structured Monitoring

By MedXY 08/25/2026

European experts recommend designated centers, structured diagnostic pathways, and real‑world monitoring to deliver precision therapies (MC4R agonists) safely and equitably to people with rare genetic forms of obesity.

Critical Care news Respiratory

Inflammatory Phenotypes in Severe Pneumonia: Bridging Clinical Insights and Mouse Models for Targeted Therapies

By MedXY 08/23/2026

This article explores hyperinflammatory and hypoinflammatory phenotypes in severe pneumonia, their clinical impact, and translational mouse models that inform precision therapeutic strategies.

Diabetes & Endocrinology news

Optimizing Type 2 Diabetes Treatment: Comparing Precision Approaches in the TriMaster Trial

By MedXY 08/07/2026

This article evaluates precision treatment strategies for type 2 diabetes glucose-lowering therapy, demonstrating that clinical feature-based models outperform cluster and genetic-based methods in predicting HbA1c response, guiding more effective personalized therapy choices.

Diabetes & Endocrinology news

Precision Medicine Enhances Management but Not Complications in Young-Onset Diabetes: Insights from the PRISM Randomized Trial

By MedXY 07/08/2026

The PRISM trial evaluated a precision medicine program using biogenetic markers and multidisciplinary care in Chinese young-onset diabetes patients, improving metabolic control and patient well-being but not reducing complications over three years.

Gastroenterology news

Impact of Acetaldehyde Metabolism on Alcohol-Related Inflammatory Bowel Disease Risk: A Precision Medicine Perspective

By MedXY 07/03/2026

This study elucidates how genetic differences in acetaldehyde metabolism modify the risk of alcohol-associated inflammatory bowel disease (IBD), highlighting personalized prevention strategies.

Cardiology Diabetes & Endocrinology news

Precision Prescribing of SGLT2 Inhibitors in People With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study

By MedXY 06/10/2026

The SABRE model estimates which people with type 2 diabetes may benefit most from SGLT2 inhibitors to prevent heart failure before it develops.

Cardiology Diabetes & Endocrinology news

Precision Prescribing of SGLT2 Inhibitors in Type 2 Diabetes for Primary Prevention of Heart Failure

By MedXY 06/03/2026

A validated model, SABRE, estimates who with type 2 diabetes may gain the most heart-failure prevention benefit from SGLT2 inhibitors, enabling more precise, individualized prescribing.

Clinical Updates news Psychiatry

Integrating Rare and Common Variants: The Synergistic Role of rCNVs and Polygenic Scores in Psychiatric Risk Stratification

By MedXY 05/31/2026

This review synthesizes evidence on how recurrent copy number variants (rCNVs) and polygenic scores (PGSs) jointly influence psychiatric risk, highlighting their complementary roles in clinical risk assessment and the emergence of precision subtyping in neurodevelopmental disorders.

Cardiology news Respiratory

Cardiovascular Benefit of CPAP May Be Greater in High-Risk Obstructive Sleep Apnoea

By MedXY 05/15/2026

This pooled analysis found that CPAP may lower cardiovascular event risk mainly in patients with high-risk obstructive sleep apnoea, especially those with stronger heart-rate surges or greater oxygen deprivation during sleep.

Clinical Updates Neurology news Pathology & Lab Medicine

Precision Blood-Based Diagnostics for Alzheimer’s Disease: The Synergistic Role of Plasma p-tau217 and eMTBR-tau243

By MedXY 04/07/2026

This review synthesizes recent clinical evidence on the integration of plasma p-tau217 and eMTBR-tau243, highlighting how sequential biomarker testing improves the diagnosis of symptomatic Alzheimer’s disease and predicts longitudinal cognitive decline.

Cardiology Clinical Updates Diabetes & Endocrinology news

Precision Phenotyping in Cardiometabolic Medicine: Genetic Susceptibility of Diabetes Subtypes and Coronary Artery Disease Risk

By MedXY 04/01/2026

This review synthesizes evidence on the genetic architecture of adult-onset diabetes subtypes, highlighting that Moderate Obesity-related Diabetes (MOD) is uniquely and causally linked to coronary artery disease risk through polygenic and Mendelian randomization analyses.

Diabetes & Endocrinology news

Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus

By MedXY 03/22/2026

A groundbreaking machine learning study of over 37,000 patients identifies four distinct GDM phenotypic clusters. These findings demonstrate that early-diagnosed, high-comorbidity phenotypes carry a four-fold increased risk of postpartum diabetes, signaling a need for personalized clinical management in obstetric care.

Cardiology news Pediatrics

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome

By MedXY 03/11/2026

A breakthrough study reveals that specific FBN1 genotypes, particularly in-frame variants in the DNCD region, significantly elevate the risk of early mitral valve surgery in Marfan syndrome patients, paving the way for genotype-guided clinical surveillance.

Gastroenterology news Oncology

Global Diversity in Autoimmune Gastritis: Deciphering Regional Phenotypes and Neoplastic Risks

By MedXY 03/09/2026

An international multicentre study of 1,240 patients reveals that autoimmune gastritis presentation varies by region, with distinct risk factors—including age, intestinal metaplasia, and extreme hypergastrinemia—driving the development of gastric adenocarcinoma and neuroendocrine tumors.